Meridian Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Withdraws registration statement filed with the Securities and Exchange Commission for the proposed sale of 2 mil. shares of common stock, citing "unsettled market conditions affecting companies related to the health care industry." The Cincinnati immunodiagnostic firm's chairman, William Motto, said in a July 29 press release that the firm "was unwilling to sell shares at a price level which failed to recognize the company's record of growth and its expectations".